Form 4: Baldwin Insurance Group Officer Sells Over $1.5 Million in Company Stock

James Morgan Roche, a key officer at Baldwin Insurance Group, Inc., has sold a significant portion of his Class A Common Stock holdings in two transactions totaling 37,573 shares for approximately $1.5 million.

Summary

• James Morgan Roche, President of The Baldwin Group and CEO of Underwriting, Capacity and Technology Operations for Baldwin Insurance Group, Inc. (BWIN), reported sales of Class A Common Stock.
• On June 12, 2025, Mr. Roche sold 10,894 shares of Class A Common Stock at a weighted average price of $40.03 per share, totaling approximately $436,108.
• The shares sold on June 12, 2025, ranged in price from $40.00 to $40.11.
• Following this transaction, Mr. Roche beneficially owned 68,792 shares of Class A Common Stock.
• On June 13, 2025, Mr. Roche sold an additional 26,679 shares of Class A Common Stock at a weighted average price of $40.07 per share, totaling approximately $1,069,000.
• The shares sold on June 13, 2025, ranged in price from $40.00 to $40.19.
• After both reported transactions, Mr. Roche's direct beneficial ownership of Class A Common Stock stands at 42,113 shares.
• The transactions were made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.

Sentiment

Score: 3

Explanation: The sentiment is moderately negative due to a high-ranking officer selling a significant number of shares, which can be interpreted as a lack of confidence or a belief that the stock is fully valued. While the sales were made under a 10b5-1 plan, the sheer volume can still raise concerns.

Negatives

• A key officer selling a substantial number of shares (37,573 shares) could be perceived negatively by investors, potentially signaling a lack of confidence in the company's near-term prospects or a belief that the stock is fully valued.
• The total value of shares sold, approximately $1.5 million, represents a significant divestment by an insider.

Risks

• Insider selling, especially by a high-ranking officer, can lead to negative investor sentiment and potentially put downward pressure on the company's stock price.
• The market may interpret these sales as a signal that the insider believes the stock price has peaked or that future growth may be limited.

Future Outlook

This Form 4 filing is a disclosure of past transactions and does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing reports an individual insider transaction and does not provide broader industry context or trends. However, insider selling activity is a data point often monitored by investors within the insurance sector to gauge management's confidence.

Related Party Transactions

• The reported transactions are insider sales by James Morgan Roche, an officer of Baldwin Insurance Group, Inc., which are considered related party transactions in the context of corporate governance and disclosure.

Stakeholder Impact

• Shareholders: May view the insider selling as a negative signal, potentially leading to decreased investor confidence and downward pressure on the stock price.
• Employees: No direct impact mentioned, but significant insider selling can sometimes affect employee morale if interpreted negatively.

Key Dates

Recommendation

Keywords

Baldwin Insurance Group, BWIN, SEC Form 4, Insider Trading, Stock Sale, Officer Transaction, Class A Common Stock, James Morgan Roche, Equity Sales